Old Web
English
Sign In
Acemap
>
authorDetail
>
Cynthia Elesinmogun
Cynthia Elesinmogun
AstraZeneca
Medicine
Oncology
Internal medicine
Immunology
CD22
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pooled Safety Summary for Patients Treated with the CD22-Directed Cytotoxin Moxetumomab Pasudotox-tdfk
2019
Clinical Lymphoma, Myeloma & Leukemia
Robert J. Kreitman
Steven Coutre
Cynthia Elesinmogun
Nataliya Kuptsova-Clarkson
Xia Li
Ira Pastan
Douglas E. Gladstone
Show All
Source
Cite
Save
Citations (0)
Treatment Patterns and Outcomes of 1205 Patients on Novel Agents in the US Veterans Health Administration (VHA) System: Results from the Largest Retrospective EMR and Chart Review Study in the Real-World Setting
2019
Blood
Christopher R. Frei
Hannah Le
Daniel McHugh
Cynthia Elesinmogun
Samantha Galley
Kathleen Franklin
Juan Tavera
Michelle Janania Martinez
David Gregorio
Snegha Ananth
Ricardo Uribe
Prathibha Surapaneni
Manuel Ricardo Espinoza-Gutarra
Michael Song
Xavier Jones
Chengwen Teng
Obiageri O. Obodozie-Ofoegbu
Zohra Nooruddin
Show All
Source
Cite
Save
Citations (2)
A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents: Treatment Patterns, Outcomes, and Patient-Reported Health-Related Quality of Life
2019
Blood
Chaitra S. Ujjani
Anthony R. Mato
Jonathon B. Cohen
Jakub Svoboda
David Andorsky
Andre Goy
Michael Wang
Anita Kumar
Peggy Ann Torney
Michelle Dawson
Cynthia Elesinmogun
Shaum M Kabadi
Brian Seal
John M. Pagel
Scott D. Ramsey
Show All
Source
Cite
Save
Citations (0)
Pooled safety summary for patients treated with the CD22-directed cytotoxin moxetumomab pasudotox-tdfk.
2019
Journal of Clinical Oncology
Robert J. Kreitman
Steven Coutre
Cynthia Elesinmogun
Nataliya Kuptsova-Clarkson
Xia Li
Ira Pastan
Douglas E. Gladstone
Show All
Source
Cite
Save
Citations (0)
1